Back

Evaluating diagnostic scoring systems for early detection of transthyretin amyloidosis in patients with HFpEF and left ventricular hypertrophy

31 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Cardiac amyloidosis (3) Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Denise Cristiana Faro

Catania (Italy)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor M. Dicorato (Bari, IT)
Abstract Video
Presentation thumbnail
Doctor I. Simkova (Olomouc, CZ)
Abstract
Presentation thumbnail
Doctor S. Yoshida (Kanazawa, JP)
Abstract
Presentation thumbnail
Doctor D. Tsilakis (Athens, GR)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Cardiac amyloidosis (3)

The Event

Event poster

ESC Congress 2025

31 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
True prevalence of transthyretin cardiac amyloidosis in an unselected heart failure with preserved ejection fraction cohort
thumbnail
Congress Presentation
Validation of two simple scores to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Validation of two clinical scores for transthyretin amyloid cardiomyopathy in a mediterranean cohort of patients at risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources